CYP450 Assay Kits

Assay Principle

The cytochrome P450 (CYP450) enzyme superfamily, including isoforms such as CYP2D6 and CYP3A4, metabolizes a substantial share of clinically used drugs, converting them into more polar, excretable metabolites through oxidation reactions. A CYP450 assay typically measures this activity using isoform-specific fluorometric kits, in which a substrate is converted by CYP450 into a fluorescent product, with detection wavelengths tailored to the specific probe substrate (for example, around Ex/Em 390/468 nm for one CYP2D6 kit), and enzyme activity is calculated by reference to a fluorescent standard. Luminescence-based platforms are also widely used in this space, employing a luciferin-based probe substrate that CYP450 metabolizes to generate a luminescent signal proportional to enzyme activity, a format especially popular for high-throughput drug interaction screening. Because each isoform requires a distinct probe substrate selective for its metabolic activity, kits are generally isoform-specific rather than measuring total CYP450 activity as a single value.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are commonly validated using liver microsomes, reflecting the liver's role as the primary site of CYP450-mediated drug metabolism, though recombinant enzyme preparations are also used for more controlled kinetic studies. Fluorometric kits can require relatively long assay times, sometimes over two hours, and report sensitivity in the sub-U/L range with modest sample volume requirements (on the order of 20 µL of liver microsome homogenate). Because CYP450 isoforms differ substantially in their expression levels and catalytic efficiency, comparing activity across isoforms or across species requires care, since a detection range well suited to one isoform's typical activity level may not suit another.

Assay Kit Purchasing Considerations

The most important comparison point for a CYP450 assay kit is isoform specificity: confirming that a kit's probe substrate is selective for the CYP450 isoform of research interest is essential, since cross-reactivity with other isoforms would confound interpretation, particularly in complex matrices like liver microsomes that express multiple isoforms simultaneously. For high-throughput drug interaction screening, luminescence-based platforms generally offer better throughput and dynamic range than fluorometric alternatives, while fluorometric kits may be preferable for labs already equipped with fluorescence plate readers and working with smaller sample sets. Given that CYP450 research often involves testing candidate drugs as potential inhibitors or inducers, confirming that a kit's assay window and control compounds (known inhibitors or inducers of the isoform in question) are well characterized is a useful step before committing to a large screening campaign. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.